• Publications
  • Influence
Role of Ki-67, P53 and Bcl-2 in Advanced Colorectal Carcinoma (Histopathological and Immunohistochemical Study)
TLDR
The immunohistochemical evaluation of Ki-67, P53 and bcl-2 yields refined information on colorectal tumor biology with statistically significant relations with tumor grade and stage, which could be integrated with the clinical and biologic tumoral framework for good assessment of the studied cases. Expand
The role of H. pylori infection in gall bladder cancer: clinicopathological study
TLDR
The role of H. pylori infection in aggravating the mucosal lesions of the gallbladders of patients operated on for chronic cholecystitis that is considered potentially precancerous is highlighted. Expand
Sexual Dysfunction in Males with Hepatitis C Virus: Relevance to Histopathologic Changes and Peginterferon Treatment
TLDR
Age and advanced liver fibrosis were important factors in inducing SD, and this is of key importance for clinical practice as it modifies the management of HCV patients. Expand
Osteoporosis in Chronic Hepatitis C Virus with Advanced Liver Fibrosis
TLDR
The study showed an association between advanced stage of liver fibrosis, the level of viremia and decreased BMD in chronic HCV patients, and replacement therapy for osteoporosis in advanced Liver fibrosis caused by HCV is recommended. Expand
P53 protein and Ki-67 expression in chronic gastritis patients with positive Helicobacter pylori infection
TLDR
It could be concluded that the significant association of the proliferative marker Ki-67 and apoptotic marker p53 protein with intestinal dysplasia may be one of the main predictive values in the development of gastric carcinoma in patients with gastritis secondary to H. pylori infection. Expand
Management of rare side effects of peginterferon and ribavirin therapy during hepatitis C treatment: a case report
TLDR
Readjustment of the dose of pegylated interferon α2b therapy to avoid these serious side effects is suggested to avoid cardiac arrhythmias and syncope. Expand
Thyroid Dysfunction as Predictor of Sustained Virological Response ( SVR ) During HCV Treatment with PEGylated Interferon and Ribavirin
Background: Thyroid disease (TD) is the most common endocrine disorder associated with HCV infection, especially in conjunction with interferon-α (IFN-α)-based therapy. The aim of the work was toExpand
Interferon Induced Ulcerative Colitis in Chronic HCV Patients : Management and Review of Literature
Background: Interferon induces ulcerative colitis in chronic HCV patients treated with PegIFN and ribavirin therapy. The aim of the work is to assess the role of interferon in inducing ulcerativeExpand
FECAL CALPROTECTIN AND CRP AS BIOCHEMICAL MARKERS IN PREDICTING INFLAMMATORY BOWEL DISEASE ACTIVITY IN PATIENTS WITH ULCERATIVE COLITIS
TLDR
Serial measurements of FC and CRP could be recommended for patients with UC to assess disease activity, induction and maintenance of remission, response to treatment, and recurrence of activity. Expand
Assessment of Fibrosis in Cases with Hepatitis C Infection ; a Comparative Study Between Liver Transient Elastography and Liver Biopsy ( using Routine and Immunohistochemical Staining )
Hepatitis C virus (HCV) infection and its complications are among the leading public health challenges in the world especially in Egypt. The prognosis and management of chronic liver diseases dependExpand
...
1
2
...